Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

Padmanabhan, Balasundaram, Tong, Kit I., Ohta, Tsutomu, Nakamura, Yoshihiro, Scharlock, Maria, Ohtsuji, Makiko, Kang, Moon-Il, Kobayashi, Akira +2 more·2006·Molecular Cell

Cited by (749)

Items 101–200 of 749

  1. Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases
    Canning, Peter, Cooper, Christopher D.O., Krojer, Tobias, Murray, James W., Pike, Ashley C.W., Chaikuad, Apirat, Keates, Tracy, Thangaratnarajah, Chancievan, Hojzan, Viktorija, Marsden, Brian D. et al. · 2013 · Journal of Biological Chemistry
  2. The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
    Simone Adinolfi, Tommi Patinen, Ashik Jawahar Deen, Sini Pitkänen, Jouni Härkönen, Emilia Kansanen, Jenni Küblbeck, Anna–Liisa Levonen · 2023 · Redox Biology
  3. Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases
    Shruti Singh, Sonal Vrishni, Brijesh Kumar Singh, Irfan Rahman, Poonam Kakkar · 2010 · Free Radical Research
  4. NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α
    Tae‐Hyoung Kim, Eu-gene Hur, Sujin Kang, Jung‐Ae Kim, Dinesh Thapa, You Mie Lee, Sae‐Kwang Ku, Yunjin Jung, Mi‐Kyoung Kwak · 2011 · Cancer Research
  5. Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1
    Takafumi Suzuki, Aki Muramatsu, Ryota Saito, Tatsuro Iso, Takahiro Shibata, Keiko Kuwata, Shin-ichi Kawaguchi, Takao Iwawaki, Saki Adachi, Hiromi Suda et al. · 2019 · Cell Reports
  6. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications
    Genschik, Pascal, Sumara, Izabela, Lechner, Esther · 2013 · The EMBO Journal
  7. High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
    Jiang, Tao, Chen, Ning, Zhao, Fei, Wang, Xiao-Jun, Kong, Beihua, Zheng, Wenxin, Zhang, Donna D. · 2010 · Cancer Research
  8. p62/SQSTM1 – steering the cell through health and disease
    Pablo Sánchez‐Martín, Masaaki Komatsu · 2018 · Journal of Cell Science
  9. NRF2 addiction in cancer cells
    Hiroshi Kitamura, Hozumi Motohashi · 2018 · Cancer Science
  10. Expression of xCT and activity of system xc− are regulated by NRF2 in human breast cancer cells in response to oxidative stress
    Eric Habib, Katja Linher‐Melville, Hanxin Lin, Gurmit Singh · 2015 · Redox Biology
  11. Expanding roles of superoxide dismutases in cell regulation and cancer
    Meixia Che, Ren Wang, Xiaoxing Li, Hui‐Yun Wang, X.F. Steven Zheng · 2015 · Drug Discovery Today
  12. KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
    Enrique Crisman, Pablo Duarte, Esteban Daudén, Antonio Cuadrado, Marı́a Isabel Rodrı́guez-Franco, Manuela G. López, Rafael M. Leon · 2022 · Medicinal Research Reviews
  13. Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1
    Toshiaki Fukutomi, Kenji Takagi, Tsunehiro Mizushima, Noriaki Ohuchi, Masayuki P. Yamamoto · 2013 · Molecular and Cellular Biology
  14. Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
    Zhengyu Jiang, Mengchen Lu, Lili Xu, Tingting Yang, Meiyang Xi, Xiaoli Xu, Xiaoke Guo, Xiaojin Zhang, Qidong You, Hao-Peng Sun · 2014 · Journal of Medicinal Chemistry
  15. Update on the Kelch-like (KLHL) gene family
    Bajinder S Dhanoa, Tiziana Cogliati, Akhila G. Satish, Elspeth A. Bruford, James S. Friedman · 2013 · Human Genomics
  16. NRF2, a Superstar of Ferroptosis
    Ruolan Yan, Bingyi Lin, Wenwei Jin, Ling Tang, Shuming Hu, Rong Cai · 2023 · Antioxidants
  17. Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
    Adcock, Ian M., Caramori, Gaetano, Barnes, Peter J. · 2011 · Respiration
  18. Human prx1 Gene Is a Target of Nrf2 and Is Up-regulated by Hypoxia/Reoxygenation: Implication to Tumor Biology
    Yun-Jeong Kim, Jiyeon Ahn, Ping Liang, Clement C.Y. Ip, Yuesheng Zhang, Young-Mee Park · 2007 · Cancer Research
  19. Review of Molecular Mechanisms Involved in the Activation of the Nrf2-ARE Signaling Pathway by Chemopreventive Agents
    Aldo Giudice, Claudio Arra, Maria Caterina Turco · 2010 · Methods in molecular biology
  20. Born to bind: the BTB protein–protein interaction domain
    R. Pérez-Torrado, D. Yamada, P. Defossez · 2006 · Bioessays
  21. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
    Charles J. Woodrow, Nicholas John White · 2016 · FEMS Microbiology Reviews
  22. Thirty years of NRF2: advances and therapeutic challenges.
    Zhang, Donna D. · 2025 · Nature Reviews Drug Discovery
  23. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression
    Jong Hun Lee, Tin Oo Khor, Limin Shu, Zheng‐Yuan Su, Francisco Fuentes, Ah‐Ng Tony Kong · 2012 · Pharmacology & Therapeutics
  24. Nrf2 protects against airway disorders
    Hye‐Youn Cho, Steven R. Kleeberger · 2009 · Toxicology and Applied Pharmacology
  25. Molecular mechanisms of natural products in chemoprevention: Induction of cytoprotective enzymes by Nrf2
    Aimee L. Eggler, Kelly A. Gay, Andrew D. Mesecar · 2008 · Molecular Nutrition & Food Research
  26. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains
    Toshihiko Ogura, Kit I. Tong, Kazuhiro Mio, Yuusuke Maruyama, Hirofumi Kurokawa, Chikara Sato, Masayuki P. Yamamoto · 2010 · Proceedings of the National Academy of Sciences
  27. The rise of antioxidant signaling—The evolution and hormetic actions of Nrf2
    Jonathan M. Maher, Masayuki P. Yamamoto · 2010 · Toxicology and Applied Pharmacology
  28. The Keap1-Nrf2 system and diabetes mellitus
    Uruno, Akira, Yagishita, Yoko, Yamamoto, Masayuki · 2015 · Archives of Biochemistry and Biophysics
  29. Arsenic Inhibits Autophagic Flux, Activating the Nrf2-Keap1 Pathway in a p62-Dependent Manner
    Alexandria Lau, Yi Zheng, Shasha Tao, Huihui Wang, Samantha A. Whitman, Eileen White, Donna D. Zhang · 2013 · Molecular and Cellular Biology
  30. Structural assembly of cullin-RING ubiquitin ligase complexes
    Zimmerman, Erik S, Schulman, Brenda A, Zheng, Ning · 2010 · Current Opinion in Structural Biology
  31. Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
    Keiko Taguchi, Jonathan M. Maher, Takafumi Suzuki, Yukie Kawatani, Hozumi Motohashi, Masayuki P. Yamamoto · 2010 · Molecular and Cellular Biology
  32. Roles of Nrf2 in cell proliferation and differentiation
    Shohei Murakami, Hozumi Motohashi · 2015 · Free Radical Biology and Medicine
  33. The CUL3–KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction
    Akihito Ohta, Frances‐Rose Schumacher, Youcef Mehellou, Clare Johnson, Axel Knebel, Thomas Macartney, Nicola T. Wood, Dario R. Alessi, Thimo Kurz · 2013 · Biochemical Journal
  34. Suppression of NF-κB signaling by KEAP1 regulation of IKKβ activity through autophagic degradation and inhibition of phosphorylation
    Jeong-eun Kim, Dong‐Joo You, Cheolju Lee, Curie Ahn, Jae Young Seong, Jong‐Ik Hwang · 2010 · Cellular Signalling
  35. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance
    Suryakant K. Niture, Anil K. Jaiswal · 2012 · Free Radical Biology and Medicine
  36. Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria
    In-geun Ryoo, Mi‐Kyoung Kwak · 2018 · Toxicology and Applied Pharmacology
  37. Somatic mutations of the KEAP1 gene in common solid cancers
    Nam Jin Yoo, Hyung Ran Kim, Yoo Ri Kim, Chang Hyeok An, Sug Hyung Lee · 2012 · Histopathology
  38. Adaptation to Oxidative Stress, Chemoresistance, and Cell Survival
    Matteo Landriscina, Francesca Maddalena, Gabriella Laudiero, Franca Esposito · 2009 · Antioxidants and Redox Signaling
  39. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
    Douglas B. Fox, Nina Marie G. Garcia, Brock J. McKinney, Ryan Lupo, Laura C. Noteware, Rachel Newcomb, Juan Liu, Jason W. Locasale, Matthew D. Hirschey, James V. Alvarez · 2020 · Nature Metabolism
  40. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
    Nioi, Paul, Nguyen, Truyen · 2007 · Biochemical and Biophysical Research Communications
  41. Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
    Anju Singh, Manish Bodas, Nobunao Wakabayashi, Fred Bunz, Shyam S. Biswal · 2010 · Antioxidants and Redox Signaling
  42. An Auto-regulatory Loop between Stress Sensors INrf2 and Nrf2 Controls Their Cellular Abundance
    Ok-Hee Lee, Abhinav K. Jain, Victor Z. Papusha, Anil K. Jaiswal · 2007 · Journal of Biological Chemistry
  43. Oncogenic functions of the transcription factor Nrf2
    Irene Gañán‐Gómez, Yue Wei, Hui Yang, M. C. Boyano-Adánez, Guillermo Garcia‐Manero · 2013 · Free Radical Biology and Medicine
  44. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex
    Lo, Shih-Ching, Hannink, Mark · 2006 · Journal of Biological Chemistry
  45. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
    Hironori Satoh, Takashi Moriguchi, Keiko Taguchi, Jun Takai, Jonathan M. Maher, Takafumi Suzuki, Paul T. Winnard, Venu Raman, Masahito Ebina, Toshihiro Nukiwa et al. · 2010 · Carcinogenesis
  46. The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
    Taguchi, Keiko, Yamamoto, Masayuki · 2020 · Cancers
  47. Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism
    Yuta Horie, Takafumi Suzuki, Jin Inoue, Tatsuro Iso, Geoffrey Wells, Terry W. Moore, Tsunehiro Mizushima, Albena T. Dinkova‐Kostova, Takuma Kasai, Takashi Kamei et al. · 2021 · Communications Biology
  48. Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype
    Anju Singh, Hailong Wu, Ping Zhang, Christine Happel, Jinfang Ma, Shyam S. Biswal · 2010 · Molecular Cancer Therapeutics
  49. PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
    Jianglin Ma, Hong Cai, Tongde Wu, Bijan Sobhian, Yanying Huo, Allen L. Alcivar, Monal Mehta, Ka Lung Cheung, Shridar Ganesan, Ah‐Ng Tony Kong et al. · 2012 · Molecular and Cellular Biology
  50. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-δ-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance
    Suryakant K. Niture, Abhinav K. Jain, Anil K. Jaiswal · 2009 · Journal of Cell Science · Retracted
  51. Methylation of the KEAP1 gene promoter region in human colorectal cancer
    Naoyuki Hanada, Takenori Takahata, Qiliang Zhou, Xulu Ye, Ruowen Sun, Jugoh Itoh, Atsushi Ishiguro, Hiroshi Kijima, Junsei Mimura, Ken Itoh et al. · 2012 · BMC Cancer
  52. The Nrf2 Pathway in Liver Diseases
    Jiaming Zhou, Qiuxian Zheng, Zhi Chen · 2022 · Frontiers in Cell and Developmental Biology
  53. The Keap1–Nrf2 system as an in vivo sensor for electrophiles
    Akira Uruno, Hozumi Motohashi · 2011 · Nitric Oxide
  54. NRF2 Activation in Cancer: From DNA to Protein
    Erica W. Cloer, Dennis Goldfarb, Travis Parke Schrank, Bernard E. Weissman, Michael B. Major · 2019 · Cancer Research
  55. The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
    Christopher P. Guise, Maria Rosaria Abbattista, Rachelle S. Singleton, Samuel D. Holford, Joanna Connolly, Gabi U. Dachs, Stephen B. Fox, Robert Pollock, Justin Harvey, Parry Guilford et al. · 2010 · Cancer Research
  56. Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
    Azhwar Raghunath, Kiruthika Sundarraj, Frank Arfuso, Gautam Sethi, Ekambaram Perumal · 2018 · Cancers
  57. The transcription factor NF‐E2‐related Factor 2 (Nrf2): a protooncogene?
    Phillip M. Shelton, Anil K. Jaiswal · 2012 · The FASEB Journal
  58. Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
    Jingbo Pi, Bhalchandra A. Diwan, Yang Sun, Jie Liu, Wei Qu, Yu‐Ying He, Miroslav Stýblo, Michael P. Waalkes · 2008 · Free Radical Biology and Medicine
  59. Potential Applications of NRF2 Inhibitors in Cancer Therapy
    Emiliano Panieri, Luciano Saso · 2019 · Oxidative Medicine and Cellular Longevity
  60. Redox Potential of Antioxidants in Cancer Progression and Prevention
    Sajan George, Heidi Abrahamse · 2020 · Antioxidants
  61. The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer
    Donna D. Zhang · 2010 · Antioxidants and Redox Signaling
  62. p62 at the Interface of Autophagy, Oxidative Stress Signaling, and Cancer
    Ioannis P. Nezis, Harald Stenmark · 2011 · Antioxidants and Redox Signaling
  63. Ferroptosis in Cancer Treatment: Another Way to Rome
    Yinan Wu, Chengcheng Yu, Meng Luo, Cen Chen, Jili Qiu, Suzhan Zhang, Kaimin Hu · 2020 · Frontiers in Oncology
  64. The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?
    Ian M. Copple · 2012 · Advances in pharmacology
  65. SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer
    Wei‐Dong Lü, Yun Zuo, Yufang Feng, Min Zhang · 2014 · Tumor Biology
  66. Keap Calm, and Carry on Covalently
    Wilson, Anthony J., Kerns, Jeffrey K., Callahan, James F., Moody, Christopher J. · 2013 · Journal of Medicinal Chemistry
  67. Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention
    Bryan G. Harder, Tao Jiang, Tongde Wu, Shasha Tao, Montserrat Rojo de la Vega, Wang Tian, Eli Chapman, Donna D. Zhang · 2015 · Biochemical Society Transactions
  68. Metabolic rewiring in melanoma
    Boris I. Ratnikov, David A. Scott, Andrei L. Osterman, Jeffrey W. Smith, Ze’ev A. Ronai · 2016 · Oncogene
  69. Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1
    Y. Katsuragi, Y. Ichimura, M. Komatsu · 2016 · Current Opinion in Toxicology
  70. Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time
    Yuji Fuse, Makoto Kobayashi · 2017 · Molecules
  71. State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
    Sheng, Chunquan, Dong, Guoqiang, Miao, Zhenyuan, Zhang, Wannian, Wang, Wei · 2015 · Chemical Society Reviews
  72. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance
    Jeong‐Min Cho, Sarala Manandhar, Hyang‐Rim Lee, Hyun-Min Park, Mi‐Kyoung Kwak · 2007 · Cancer Letters
  73. Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
    Kouhei Tsuchida, Tadayuki Tsujita, Makiko Hayashi, Asaka Ojima, Nadine Keleku-Lukwete, Fumiki Katsuoka, Akihito Otsuki, Haruhisa Kikuchi, Yoshiteru Oshima, Mikiko Suzuki et al. · 2016 · Free Radical Biology and Medicine
  74. Roles of reactive oxygen species in inflammation and cancer
    Yunfei Yu, Shengzhuo Liu, Luchen Yang, Pan Song, Zhenghuan Liu, Xiaoyang Liu, Xin Yan, Qiang Dong · 2024 · MedComm
  75. <i>CUL3</i> and <i>NRF2</i> Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma
    Ooi, Aikseng, Dykema, Karl, Ansari, Asif, Petillo, David, Snider, John, Kahnoski, Richard, Anema, John, Craig, David, Carpten, John, Teh, Bin-Tean et al. · 2013 · Cancer Research
  76. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
    Xupeng Bai, Yibei Chen, Xiangyu Hou, Min Huang, Jing Jin · 2016 · Drug Metabolism Reviews
  77. Role of the Keap1–Nrf2 Pathway in Cancer
    Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi, Anna–Liisa Levonen · 2014 · Advances in cancer research
  78. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
    Song Chian, Ruby Thapa, Zhexu Chi, Xiu Jun Wang, Xiuwen Tang · 2014 · Biochemical and Biophysical Research Communications
  79. Redox regulation of neuronal survival mediated by electrophilic compounds
    Takumi Satoh, Stuart A. Lipton · 2006 · Trends in Neurosciences
  80. Drugging the addict: non‐oncogene addiction as a target for cancer therapy
    Remco Nagel, Ekaterina A Semenova, Anton J. M. Berns · 2016 · EMBO Reports
  81. The Critical Role of Nitric Oxide Signaling, via Protein S-Guanylation and Nitrated Cyclic GMP, in the Antioxidant Adaptive Response
    Shigemoto Fujii, Tomohiro Sawa, Hideshi Ihara, Kit I. Tong, Tomoaki Ida, Tatsuya Okamoto, Khandaker Ahtesham Ahmed, Yu Ishima, Hozumi Motohashi, Masayuki P. Yamamoto et al. · 2010 · Journal of Biological Chemistry
  82. KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants
    Bibo Ke, Xiu‐Da Shen, Yu Long Zhang, Haofeng Ji, Feng Gao, Shi Yue, Naoko Kamo, Yuan Zhai, Masayuki P. Yamamoto, Ronald W. Busuttil et al. · 2013 · Journal of Hepatology
  83. Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
    Rowena Hancock, Hélène Charlotte Bertrand, Tadayuki Tsujita, Shama Naz, Ayman El-Bakry, Jitnueng Laoruchupong, John D. Hayes, Geoffrey Wells · 2011 · Free Radical Biology and Medicine
  84. A catalogue of somatic NRF2 gain-of-function mutations in cancer
    Kerins, Michael John, Ooi, Aikseng · 2018 · Scientific Reports
  85. Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity
    Mohammad Mohammadzadeh-Vardin, Raheleh Halabian, Ahmad Gharehbaghian, Naser Amirizadeh, Ali Jahanian‐Najafabadi, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar · 2012 · Cell Stress and Chaperones
  86. Transcription factors, CncC and Maf, regulate expression of CYP6BQ genes responsible for deltamethrin resistance in Tribolium castaneum
    Megha Kalsi, Subba Reddy Palli · 2015 · Insect Biochemistry and Molecular Biology
  87. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling
    Narsa M. Reddy, Steven R. Kleeberger, Jay H. Bream, Padraic G. Fallon, Thomas W. Kensler, Masayuki P. Yamamoto, Sekhar P. Reddy · 2008 · Oncogene
  88. Sustained Activation of Nuclear Erythroid 2-Related Factor 2/Antioxidant Response Element Signaling Promotes Reductive Stress in the Human Mutant Protein Aggregation Cardiomyopathy in Mice
    Namakkal Soorappan Rajasekaran, Saradhadevi Varadharaj, Gayatri Deepti Khanderao, Christopher J. Davidson, Sankaranarayanan Kannan, Matthew A. Firpo, Jay Louis Zweier, Ivor J. Benjamin · 2010 · Antioxidants and Redox Signaling
  89. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
    Min‐Che Tung, Po-Lin Lin, Yao-Chen Wang, Tsung-Ying He, Ming-Ching Lee, Sauh-Der Yeh, Chih‐Yi Chen, Huei Lee · 2015 · Oncotarget
  90. Arsenic‐Mediated Activation of the Nrf2‐Keap1 Antioxidant Pathway
    Alexandria Lau, Samantha A. Whitman, Melba C. Jaramillo, Donna D. Zhang · 2012 · Journal of Biochemical and Molecular Toxicology
  91. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
    Pelin Telkoparan‐Akillilar, Emiliano Panieri, Dilek Cevik, Síbel Süzen, Luciano Saso · 2021 · Molecules
  92. Subcellular localization and cytoplasmic complex status of endogenous Keap1
    Yoriko Watai, Akira Kobayashi, Hiroko Nagase, Mio Mizukami, Justina D. McEvoy, Jeffrey D. Singer, Ken Itoh, Masayuki P. Yamamoto · 2007 · Genes to Cells
  93. The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
    Antonio Cuadrado, Paz Moreno-Murciano, José Pedraza‐Chaverrí · 2009 · Expert Opinion on Therapeutic Targets
  94. The Double-Edged Sword of Nrf2: Subversion of Redox Homeostasis during the Evolution of Cancer
    John D. Hayes, Michael J. McMahon · 2006 · Molecular Cell
  95. Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
    Lucia Anna Muscarella, Paola Parrella, Vito D’Alessandro, Annamaria la Torre, Raffaela Barbano, Andrea Fontana, Antonio Tancredi, Vito Guarnieri, Teresa Balsamo, Michelina Coco et al. · 2011 · Epigenetics
  96. The hepatotoxic metabolite of acetaminophen directly activates the Keap1‐Nrf2 cell defense system†
    Ian M. Copple, Christopher E. Goldring, Rosalind E. Jenkins, Alvin J. L. Chia, Laura E. Randle, John D. Hayes, Neil R. Kitteringham, B. Kevin Park · 2008 · Hepatology
  97. Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy
    Priyanka Basak, Pritam Sadhukhan, Poulami Sarkar, Parames Chandra Sil · 2017 · Toxicology Reports
  98. The mutational landscape of hepatocellular carcinoma
    Ju‐Seog Lee · 2015 · Clinical and Molecular Hepatology
  99. Critical role of Nrf2 in oxidative stress‐induced retinal ganglion cell death
    Noriko Himori, Kotaro T. Yamamoto, Kazuichi Maruyama, Morin Ryu, Keiko Taguchi, Masayuki P. Yamamoto, Toru Nakazawa · 2013 · Journal of Neurochemistry
  100. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance
    In-geun Ryoo, Sang-hwan Lee, Mi-Kyoung Kwak · 2015 · Oxidative Medicine and Cellular Longevity